País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
LIDOCAINE HYDROCHLORIDE, EPINEPHRINE ACID TARTRATE
Chem-Pharm
QN01BB52
LIDOCAINE HYDROCHLORIDE, EPINEPHRINE ACID TARTRATE
Unknown
Solution for Injection
VPO-Vet.Practitioner Only
Equine - Food
Lidocaine, combinations
Neurological Preparations
Authorised
2000-10-01
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) VPA: 10823/019/001 Case No: 7007641 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: CHEM-PHARM BALLYVAUGHAN, CO. CLARE, IRELAND an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: LIGNOCAINE & ADRENALINE SOLUTION FOR INJECTION The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. The authorisation, unless previously revoked, shall continue in force from 16/04/2010. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: From this date of effect, this authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 20/04/2010_ _CRN 7007641_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Lignocaine & Adrenaline Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For infiltration anaesthesia (local or field block) and regional anaesthesia. 4.3 CONTRAINDICATIONS Do not administer by intravenous injection. 4.4 SPECIAL WARNINGS Leer el documento completo